This year, we raised $225,421 from 193 whispers, voices and shouts. We far surpassed our $1 million goal and have now raised a cumulative $1,051,780 for metastatic breast cancer research. Our winning hunches are named in memory of Mary Corbett and Anne Abernethy. Both focus on triple negative breast cancer, the most aggressive and deadly form of breast cancer. One targets immunotherapy, a promising new avenue for therapy that uses drugs to train the body to attack its own cancer. The second tests a drug combination that has been shown to be highly effective and should be able to move to clinical trial quickly.
On Dec. 2, we gathered for our largest annual meeting to date. You can watch the video from the event to learn more about each of the four hunches presented.
In 2015, we raised $117,850 bringing our total to more than $825,000. The winning hunch was proposed by a team that represents expertise in biomedical engineering, nanotechnology and mechanical engineering at Purdue University. They will be developing a proof-of-concept nanomachine that can detect and destroy cancer cells as they migrate in the bloodstream.
External news coverage
Indianapolis Star (Oct. 2015): PDF
Indianapolis Star (Nov. 2008): PDF